Welcome to FertiPROTEKT


Wer sind wir?

in 2006, the FertiPROTEKT network was founded. It has meanwhile been extended to cover all German-speaking countries (Germany, Switzer­land, Austria).

It gives women and men facing or having gone through chemo- or radio­ther­apy the chance to obtain the most recent sci­entif­ic advice about their fertility and the measures which can be taken to protect it.
By contrast to men, where the pre­ser­va­tion of sperm is an estab­lished method, effective tech­niques of fertility pro­tec­tion for women have only been around for a few years.

Fer­ti­PRO­TEKT is inter­na­tion­ally one of the the first networks offering these tech­niques to a whole nation. Within the network, these methods are being estab­lished, further developed and tested in terms of their effect­ive­ness. Accord­ingly, all centres of the network meet strict con­stantly con­trolled and optimised standards of con­sultancy and therapy.

Currently, the network covers mostly uni­ver­sity centres working locally and in close cooper­a­tion with onco­lo­gists of all dis­cip­lines. Further uni­ver­sity centres, hospitals and private fertility clinics meeting the strict quality standards are joining the network.

The Fer­ti­PRO­TEKT homepage informs you about the back­ground and therapies, costs and effect­ive­ness (“Illnesses” and “Treatment methods”). You can also find out about the structure of the network (“Fer­ti­PRO­TEKT — The Network”) as well as about the stat­ist­ic­al data of the patients treated by Fer­ti­PRO­TEKT (“Fer­ti­PRO­TEKT — The Register”) and recom­men­ded contact addresses of Fer­ti­PRO­TEKT centres (“Cooper­at­ing centers and contacts”). If any inform­a­tion on the homepage seems unclear to you or you have problems with the contact, the advice or the therapy provided by one of the centres, please do not hesitate to inform the coordin­at­ors. A trans­la­tion into English is coming soon.

We hope to be offering plenty of inform­a­tion on our homepage and wish you and your patients good health and all the best,

Your Fer­ti­PRO­TEKT team

Such­maschine wird geladen…

Other malignant diseases

Here you will find inform­a­tion about fertility pre­ser­va­tion relating to other malig­nan­cies and cancers.

Childhood cancer

Here you will find inform­a­tion about fertility pre­ser­va­tion in children who are affected by a malignant disease.

Turner syndrome

Turner syndrome is a genetic disorder (inherited disease) where there is the loss of an X chro­mo­some or a lim­it­a­tion of its function.

Endo­metri­al cancer

Endo­metri­al carcinoma affects women under the age of 40 in 3–14% of cases.

Ovarian tumours

Ovarian tumours can be varied in nature. So-called bor­der­line tumours make up 31%, epi­theli­al tumours 50% and malignant germ cell tumours 19% during repro­duct­ive age. These tumours have different prognoses.


Cervical cancer is still the second most common cancer in women worldwide. Currently, one in two women is under 35 years of age at the time of initial diagnosis.

Rheumatic diseases

Autoim­mune diseases often affect young women of child­bear­ing age. Despite large advances in treatment, general rheumatic diseases such as con­nect­ive tissue diseases and vas­cu­lit­is are still often the reason for chemotherapy.

Hodgkin Lymphoma

This cancer of the lymphatic system is often diagnosed in women of repro­duct­ive age. With appro­pri­ate chemo­ther­apy, it has a very high cure rate. 


Male germ cells (sperm) can be cryo­p­reserved (frozen) before chemo­ther­apy or radio­ther­apy and, in the case of a loss of function of a male patient’s gonads (testes), are used to conceive his own child.


The aim of moving the ovaries (trans­pos­i­tion of the ovaries) is to retain their function despite planned radio­ther­apy. The goals are the pre­ser­va­tion of hormone pro­duc­tion and also the pos­sib­il­ity of pregnancy after onco­lo­gic­al treatment